Celanese Corporation Reports Third Quarter Earnings; Expects to Deliver 2017 Results at Higher End of Outlook

SHARE


DALLAS–(BUSINESS WIRE)–
Celanese Corporation (NYSE: CE), a global technology and specialty
materials company, today reported third quarter 2017 GAAP diluted
earnings per share of $1.68, second-highest for a third quarter, and
adjusted earnings per share of $1.93, an all-time record. Net sales
expanded 18 percent year over year to $1.6 billion. A combination of
commercial execution in the Acetyl Chain, extension of the pipeline
model in Materials Solutions, and broad productivity gains more than
offset the expected declines in tow earnings to deliver robust results.
The Acetyl Chain grew profitability by exercising the optionality in its
commercial model to overcome the disruption from Hurricane Harvey.
Advanced Engineered Materials (AEM) grew project commercializations
across regions in both legacy and acquired polymers.

Third Quarter 2017 Financial Highlights:

   

Three Months Ended
September 30,

2017     2016
(unaudited)
(In $ millions)
Operating Profit (Loss)
Advanced Engineered Materials 97 93
Consumer Specialties 53   68  
Total Materials Solutions 150   161  
Industrial Specialties 20 25
Acetyl Intermediates 128 83
Eliminations    
Total Acetyl Chain 148   108  
Other Activities (46 ) (23 )
Total 252   246  
   
Three Months Ended
September 30,
2017     2016
(unaudited)
(In $ millions, except per share data)
Net Earnings (Loss) 228 263
 
Adjusted EBIT(1)(2)
Advanced Engineered Materials 147 127
Consumer Specialties   79     98  
Total Materials Solutions   226     225  
Industrial Specialties 23 25
Acetyl Intermediates 134 84
Eliminations        
Total Acetyl Chain   157     109  
Other Activities   (38 )   (15 )
Total   345     319  
 
Equity Earnings, Cost-Dividend Income, Other Income (Expense)
Advanced Engineered Materials 45 33
Consumer Specialties   26     27  
Total Materials Solutions   71     60  
 
Operating EBITDA(1) 423 390
Diluted EPS – continuing operations $ 1.68 $ 1.83
Diluted EPS – total $ 1.65 $ 1.81
Adjusted EPS(1) $ 1.93 $ 1.67
 
Net cash provided by (used in) investing activities (68 ) (54 )
Net cash provided by (used in) financing activities (247 ) 265
Net cash provided by (used in) operating activities 255 304
Free cash flow(1) 181 237
______________________________

(1)

  See “Non-US GAAP Financial Measures” below.

(2)

The Company’s discussion of adjusted earnings includes use of
terms such as “segment income” and “core income.” Those non-GAAP
terms are defined below and reconciled in our Non-US GAAP
Financial Measures and Supplemental Information document
referenced below.

 

Third Quarter 2017 Highlights:

  • Completed de-bottlenecking projects over the last year that increased
    output by 10 percent per unit for select POM, UHMW-PE, PPS and PBT
    assets in the US, Germany, and China.
  • Announced plans to add production lines in the US, Italy and China to
    expand compounding capacity by roughly 100 kt per year. The expansion
    will be completed in 2018-2019 and will support demand growth across
    end-market applications.
  • Commercialized a record 585 projects in the third quarter of 2017, a
    67 percent increase from third quarter of 2016, in engineered
    materials (AEM excluding affiliates). Increased target for projects
    closed in 2017 to above 2,100, up 52 percent from 2016.
  • Completed the SAP system integration of Nilit Plastics, a major
    milestone towards full integration into Celanese.
  • Advanced on the previously announced 150 kt expansion of vinyl acetate
    monomer at the Clear Lake, Texas facility. This expansion, expected to
    be commissioned at the end of 2018, will raise plant capacity to 450
    kt making it the largest VAM plant in the western hemisphere.
  • Filed for regulatory approval of the tow joint venture with Blackstone
    in all six jurisdictions and received approval in Mexico. The European
    Commission is expected to continue its assessment with a final
    decision expected in spring 2018.

Third Quarter 2017 Business Segment Overview

Materials Solutions

Materials Solutions reported record net sales of $730 million in the
third quarter, a 24 percent increase year over year driven by growth in
Advanced Engineered Materials that outpaced the decline in Consumer
Specialties. AEM delivered its highest ever third quarter GAAP operating
profit of $97 million and highest ever segment income of $147 million.
There is strong receptivity for Celanese’s customer-centric approach
coupled with the breadth of polymer solutions which continues to
strengthen AEM’s growth profile. The segment set a new watermark of
advancing 585 projects to commercialization in the quarter by expanding
the opportunity set and improving its win-rate. Volume in the third
quarter of 2017 grew over last year mainly from the Nilit and SO.F.TER.
acquisitions, growth in Asia and new projects. As expected, the addition
of the Nilit and SO.F.TER. acquisitions along with higher indirect costs
from Hurricane Harvey lowered GAAP operating profit margin and segment
income margin year over year. Both acquisitions were segment income
accretive in the quarter and their margin is expected to improve over
the next few years as synergies are realized.

Acetate tow volume and price in the third quarter declined compared to
the same quarter in 2016 due to lower tow industry capacity utilization
rates and offset improvements in productivity. Results were consistent
sequentially.

Affiliate earnings in Materials Solutions increased 18 percent year over
year to $71 million mainly due to the impact of the Ibn Sina turnaround
in the third quarter of 2016 which did not repeat in 2017.

Acetyl Chain

The Acetyl Chain GAAP operating profit of $148 million in the third
quarter was $40 million higher than the third quarter of 2016 while core
income of $157 million was $48 million higher. Profitability grew
despite operational and supply chain disruptions in the Gulf Coast
caused by Hurricane Harvey. The chain responded by swiftly executing
contingency plans to minimize impact and quickly restore operations.
Pricing was higher than the third quarter of last year driven by the
success of commercial actions mainly in Asia as well as continued
strength in global acetyls. Margin expansion in the chain was driven by
the Acetyl Intermediates segment which recorded GAAP operating margin of
18.7 percent and segment income margin of 19.6 percent, both all time
records. Results in the quarter highlight the chain’s business model
which leverages volatility in the global acetyl supply chain to maximize
profitability.

Cash Flow

Operating cash flow in the third quarter was $255 million and free cash
flow was $181 million. Capital expenditures were $64 million in the
quarter. The company repurchased approximately 2 million shares for $200
million in the quarter and $500 million total for the year. $262 million
of cash was returned to shareholders in the quarter including $62
million in dividends.

Outlook

“Success in the third quarter and for most of 2017 has come from our
ability to rapidly translate changes in the business environment into
new value creation opportunities through our business models. In
Advanced Engineered Materials, the disciplined approach to innovation
through the pipeline model has raised profits and provided a road map
for accelerating value uplift from the SO.F.TER. and Nilit acquisitions.
The Acetyl Chain is expected to maintain its commercial traction in the
quarter and additional initiatives are in place to take advantage of the
gradual strengthening of the market. There is business and productivity
momentum that should offset fourth quarter weakness. This combination
gives confidence we can grow 2017 adjusted earnings per share toward the
higher end of the 9-11 percent range, year over year,” said Mark Rohr,
chairman and chief executive officer.

We are unable to reconcile forecasted adjusted earnings per share growth
to US GAAP diluted earnings per share without unreasonable efforts
because a forecast of Certain Items, such as mark-to-market pension
gains/losses, is not practical.

The Company’s earnings presentation and prepared remarks related to the
third quarter results will be posted on its website at www.celanese.com
under Investor Relations/Events and Presentations after market close on
October 16, 2017. Information about Non-US GAAP measures is included in
a Non-US GAAP Financial Measures and Supplemental Information document
posted on the website and available at the link below. See “Non-GAAP
Financial Measures” below.

Celanese Corporation is a global technology leader in the production
of differentiated chemistry solutions and specialty materials used in
most major industries and consumer applications. Our two complementary
business cores, Acetyl Chain and Materials Solutions, use the full
breadth of Celanese’s global chemistry, technology and business
expertise to create value for our customers and the corporation. As we
partner with our customers to solve their most critical business needs,
we strive to make a positive impact on our communities and the world
through The Celanese Foundation. Based in Dallas, Celanese employs
approximately 7,500 employees worldwide and had 2016 net sales of $5.4
billion. For more information about Celanese Corporation and its product
offerings, visit
www.celanese.com
or our blog at
www.celaneseblog.com.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include
information concerning the Company’s plans, objectives, goals,
strategies, future revenues, synergies, performance, capital
expenditures, financing needs and other information that is not
historical information. All forward-looking statements are based upon
current expectations and beliefs and various assumptions, including the
announced joint venture transaction. There can be no assurance that the
Company will realize these expectations or that these beliefs will prove
correct.
There are a number of risks and uncertainties that could
cause actual results to differ materially from the results expressed or
implied in the forward-looking statements contained in this release,
including with respect to the joint venture. These risks and
uncertainties include, among other things: changes in general economic,
business, political and regulatory conditions in the countries or
regions in which we operate; the length and depth of product and
industry business cycles, particularly in the automotive, electrical,
textiles, electronics and construction industries; changes in the price
and availability of raw materials, particularly changes in the demand
for, supply of, and market prices of ethylene, methanol, natural gas,
wood pulp and fuel oil and the prices for electricity and other energy
sources; the ability to pass increases in raw material prices on to
customers or otherwise improve margins through price increases; the
ability to maintain plant utilization rates and to implement planned
capacity additions and expansions; the ability to reduce or maintain
current levels of production costs and to improve productivity by
implementing technological improvements to existing plants; the ability
to identify desirable potential acquisition targets and to consummate
acquisition or investment transactions consistent with the Company’s
strategy; increased price competition and the
introduction of
competing products by other companies; market acceptance of our
technology; the ability to obtain governmental approvals and to
construct facilities on terms and schedules acceptable to the Company;
changes in the degree of intellectual property and other legal
protection afforded to our products or technologies, or the theft of
such intellectual property; compliance and other costs and potential
disruption or interruption of production or operations due to accidents,
interruptions in sources of raw materials, cyber security incidents,
terrorism or political unrest or other unforeseen events or delays in
construction or operation of facilities, including as a result of
geopolitical conditions, the occurrence of acts of war or terrorist
incidents or as a result of weather or natural disasters; potential
liability for remedial actions and increased costs under existing or
future environmental regulations, including those relating to climate
change; potential liability resulting from pending or future litigation,
or from changes in the laws, regulations or policies of governments or
other governmental activities in the countries in which we operate;
changes in currency exchange rates and interest rates; our level of
indebtedness, which could diminish our ability to raise additional
capital to fund operations or limit our ability to react to changes in
the economy or the chemicals industry; and various other factors
discussed from time to time in the Company’s filings with the Securities
and Exchange Commission. Any forward-looking statement speaks only as of
the date on which it is made, and the Company undertakes no obligation
to update any forward-looking statements to reflect events or
circumstances after the date on which it is made or to reflect the
occurrence of anticipated or unanticipated events or circumstances.

Non-GAAP Financial Measures

Presentation

This document presents the Company’s business segments in two
subtotals, reflecting our two cores, the Acetyl Chain and Materials
Solutions, based on similarities among customers, business models and
technical processes. As described in the Company’s annual report on Form
10-K and quarterly reports on Form 10-Q, the Acetyl Chain includes the
Company’s Acetyl Intermediates segment and the Industrial Specialties
segment. Materials Solutions includes the Company’s Advanced Engineered
Materials segment and the Consumer Specialties segment.

Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT,
adjusted EBIT margin, operating EBITDA, adjusted earnings per share and
free cash flow. These measures are not recognized in accordance with US
GAAP and should not be viewed as an alternative to US GAAP measures of
performance or liquidity. The most directly comparable financial measure
presented in accordance with US GAAP in our consolidated financial
statements for adjusted EBIT and operating EBITDA is net earnings (loss)
attributable to Celanese Corporation; for adjusted EBIT margin is
operating margin; for adjusted earnings per share is earnings (loss)
from continuing operations attributable to Celanese Corporation per
common share-diluted; and for free cash flow is net cash provided by
(used in) operations.

Definitions of Non-US GAAP Financial Measures

  • Adjusted EBIT is a performance measure used by the Company and is
    defined by the Company as net earnings (loss) attributable to Celanese
    Corporation, plus (earnings) loss from discontinued operations, less
    interest income, plus interest expense, plus refinancing expense and
    taxes, and further adjusted for Certain Items (refer to Table 8 of our
    Non-US GAAP Financial Measures and Supplemental Information document).
    We may provide guidance on adjusted EBIT but are unable to reconcile
    forecasted adjusted EBIT to a US GAAP financial measure without
    unreasonable efforts because a forecast of Certain Items, such as
    mark-to-market pension gains and losses, which may be significant, is
    not practical. Adjusted EBIT margin is defined by the Company as
    adjusted EBIT divided by net sales.
  • Adjusted EBIT by core (i.e., Acetyl Chain and/or Materials
    Solutions) may also be referred to by management as core income.
    Adjusted EBIT margin by core may also be referred to by management as
    core income margin. Adjusted EBIT by business segment may also be
    referred to by management as segment income. Adjusted EBIT margin by
    business segment may also be referred to by management as segment
    income margin.
  • Operating EBITDA is a performance measure used by the Company and
    is defined by the Company as net earnings (loss) attributable to
    Celanese Corporation, plus (earnings) loss from discontinued
    operations, less interest income, plus interest expense, plus
    refinancing expense, taxes and depreciation and amortization, and
    further adjusted for Certain Items, which Certain Items include
    accelerated depreciation and amortization expense. Operating EBITDA is
    equal to adjusted EBIT plus depreciation and amortization.
  • Adjusted earnings per share is a performance measure used by the
    Company and is defined by the Company as earnings (loss) from
    continuing operations attributable to Celanese Corporation, adjusted
    for income tax (provision) benefit, Certain Items, and refinancing and
    related expenses, divided by the number of basic common shares and
    dilutive restricted stock units and stock options calculated using the
    treasury method. We may provide guidance on adjusted earnings per
    share but are unable to reconcile forecasted adjusted earnings per
    share to a US GAAP financial measure without unreasonable efforts
    because a forecast of Certain Items, such as mark-to-market pension
    gains and losses, which may be significant, is not practical.

    Note:
    The income tax expense (benefit) on Certain Items (“Non-GAAP
    adjustments”) is determined using the applicable rates in the taxing
    jurisdictions in which the Non-GAAP adjustments occurred and includes
    both current and deferred income tax expense (benefit). The income tax
    rate used for adjusted earnings per share approximates the midpoint in
    a range of forecasted tax rates for the year. This range may include
    certain partial or full-year forecasted tax opportunities and related
    costs, where applicable, and specifically excludes changes in
    uncertain tax positions, discrete recognition of GAAP items on a
    quarterly basis, other pre-tax items adjusted out of our GAAP earnings
    for adjusted earnings per share purposes and changes in management’s
    assessments regarding the ability to realize deferred tax assets for
    GAAP. In determining the adjusted earnings per share tax rate, we
    reflect the impact of foreign tax credits when utilized, or expected
    to be utilized, absent discrete events impacting the timing of foreign
    tax credit utilization. We analyze this rate quarterly and adjust it
    if there is a material change in the range of forecasted tax rates; an
    updated forecast would not necessarily result in a change to our tax
    rate used for adjusted earnings per share. The adjusted tax rate is an
    estimate and may differ from the actual tax rate used for GAAP
    reporting in any given reporting period. Table 3a of our Non-US GAAP
    Financial Measures and Supplemental Information document summarizes
    the reconciliation of our estimated GAAP effective tax rate to the
    adjusted tax rate. The estimated GAAP rate excludes discrete
    recognition of GAAP items due to our inability to forecast such items.
    As part of the year-end reconciliation, we will update the
    reconciliation of the GAAP effective tax rate to the adjusted tax rate
    for actual results.

  • Free cash flow is a liquidity measure used by the Company and is
    defined by the Company as cash flow from operations, less capital
    expenditures on property, plant and equipment, and adjusted for
    capital contributions from or distributions to Mitsui & Co., Ltd.
    (“Mitsui”) related to our methanol joint venture, Fairway Methanol LLC
    (“Fairway”).

Reconciliation of Non-US GAAP Financial Measures

Reconciliations of the Non-US GAAP financial measures used in this
press release to the comparable US GAAP financial measure, together with
information about the purposes and uses of Non-US GAAP financial
measures, are included in our Non-US GAAP Financial Measures and
Supplemental Information document filed as an exhibit to our Current
Report on Form 8-K filed with the SEC on or about October 16, 2017 and
also available on our website at
www.celanese.com
under Financial Information, Non-GAAP Financial Measures, or at this
link:
http://investors.celanese.com/interactive/lookandfeel/4103411/Non-GAAP.PDF.

Results Unaudited

The results in this document, together with the adjustments made to
present the results on a comparable basis, have not been audited and are
based on internal financial data furnished to management. Quarterly
results should not be taken as an indication of the results of
operations to be reported for any subsequent period or for the full
fiscal year.

Supplemental Information

Additional information about our prior period performance is included
in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial
Measures and Supplemental Information document.

   
 

Consolidated Statements of Operations – Unaudited

 
Three Months Ended
September 30,
2017     2016
(In $ millions, except share and per share data)
Net sales 1,566 1,323
Cost of sales (1,181 ) (968 )
Gross profit 385 355
Selling, general and administrative expenses (112 ) (81 )
Amortization of intangible assets (5 ) (3 )
Research and development expenses (19 ) (20 )
Other (charges) gains, net (3 )
Foreign exchange gain (loss), net 4 (1 )

Gain (loss) on disposition of businesses and assets, net

(1 ) (1 )
Operating profit (loss) 252 246
Equity in net earnings (loss) of affiliates 50 41
Interest expense (32 ) (28 )
Refinancing expense (4 )
Interest income 1
Dividend income – cost investments 24 26
Other income (expense), net (6 )  
Earnings (loss) from continuing operations before tax 289 281
Income tax (provision) benefit (57 ) (15 )
Earnings (loss) from continuing operations 232   266  
Earnings (loss) from operation of discontinued operations (5 ) (4 )
Income tax (provision) benefit from discontinued operations 1   1  
Earnings (loss) from discontinued operations (4 ) (3 )
Net earnings (loss) 228 263
Net (earnings) loss attributable to noncontrolling interests (2 ) (1 )
Net earnings (loss) attributable to Celanese Corporation 226   262  
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations 230 265
Earnings (loss) from discontinued operations (4 ) (3 )
Net earnings (loss) 226   262  
Earnings (loss) per common share – basic
Continuing operations 1.68 1.84
Discontinued operations (0.03 ) (0.02 )
Net earnings (loss) – basic 1.65   1.82  
Earnings (loss) per common share – diluted
Continuing operations 1.68 1.83
Discontinued operations (0.03 ) (0.02 )
Net earnings (loss) – diluted 1.65   1.81  
Weighted average shares (in millions)
Basic 136.6 144.0
Diluted 137.0 144.6
       
 

Consolidated Balance Sheets – Unaudited

 

As of
September 30,
2017

As of
December 31,
2016

(In $ millions)
ASSETS
Current Assets
Cash and cash equivalents 461 638
Trade receivables – third party and affiliates, net 989 801
Non-trade receivables, net 260 223
Inventories 809 720
Marketable securities, at fair value 31 30
Other assets 63   60  
Total current assets 2,613   2,472  
Investments in affiliates 938 852
Property, plant and equipment, net 3,706 3,577
Deferred income taxes 201 159
Other assets 306 307
Goodwill 995 796
Intangible assets, net 303   194  
Total assets 9,062   8,357  
LIABILITIES AND EQUITY
Current Liabilities
Short-term borrowings and current installments of long-term debt –
third party and affiliates
435 118
Trade payables – third party and affiliates 695 625
Other liabilities 343 322
Income taxes payable 77   12  
Total current liabilities 1,550   1,077  
Long-term debt, net of unamortized deferred financing costs 2,954 2,890
Deferred income taxes 195 130
Uncertain tax positions 153 131
Benefit obligations 845 893
Other liabilities 230 215
Commitments and Contingencies
Stockholders’ Equity
Preferred stock
Common stock
Treasury stock, at cost (2,031 ) (1,531 )
Additional paid-in capital 171 157
Retained earnings 4,781 4,320
Accumulated other comprehensive income (loss), net (206 ) (358 )
Total Celanese Corporation stockholders’ equity 2,715 2,588
Noncontrolling interests 420   433  
Total equity 3,135   3,021  
Total liabilities and equity 9,062   8,357  
 
 

Non-US GAAP Financial Measures and Supplemental
Information

October 16, 2017

In this document, the terms the “Company,” “we” and “our” refer to
Celanese Corporation and its subsidiaries on a consolidated basis.

Purpose

The purpose of this document is to provide information of interest to
investors, analysts and other parties including supplemental financial
information and reconciliations and other information concerning our use
of non-US GAAP financial measures. This document is updated quarterly.

Presentation

This document presents the Company’s business segments in two
subtotals, reflecting our two cores, the Acetyl Chain and Materials
Solutions, based on similarities among customers, business models and
technical processes. As described in the Company’s annual report on Form
10-K and quarterly reports on Form 10-Q, the Acetyl Chain includes the
Company’s Acetyl Intermediates segment and the Industrial Specialties
segment. Materials Solutions includes the Company’s Advanced Engineered
Materials segment and the Consumer Specialties segment.

Use of Non-US GAAP Financial Measures

From time to time, management may publicly disclose certain numerical
“non-GAAP financial measures” in the course of our earnings releases,
financial presentations, earnings conference calls, investor and analyst
meetings and otherwise. For these purposes, the Securities and Exchange
Commission (“SEC”) defines a “non-GAAP financial measure” as a numerical
measure of historical or future financial performance, financial
position or cash flows that excludes amounts, or is subject to
adjustments that effectively exclude amounts, included in the most
directly comparable measure calculated and presented in accordance with
US GAAP, and vice versa for measures that include amounts, or are
subject to adjustments that effectively include amounts, that are
excluded from the most directly comparable US GAAP measure so calculated
and presented. For these purposes, “GAAP” refers to generally accepted
accounting principles in the United States.

Non-GAAP financial measures disclosed by management are provided as
additional information to investors, analysts and other parties because
the Company believes them to be important supplemental measures for
assessing our financial and operating results and as a means to evaluate
our financial condition and period-to-period comparisons. These non-GAAP
financial measures should be viewed as supplemental to, and should not
be considered in isolation or as alternatives to, net earnings (loss),
operating profit (loss), operating margin, cash flow from operating
activities (together with cash flow from investing and financing
activities), earnings per share or any other US GAAP financial measure.
These non-GAAP financial measures should be considered within the
context of our complete audited and unaudited financial results for the
given period, which are available on the Investor Relations/Financial
Information/SEC Filings page of our website,
www.celanese.com.
The definition and method of calculation of the non-GAAP financial
measures used herein may be different from other companies’ methods for
calculating measures with the same or similar titles. Investors,
analysts and other parties should understand how another company
calculates such non-GAAP financial measures before comparing the other
company’s non-GAAP financial measures to any of our own. These non-GAAP
financial measures may not be indicative of the historical operating
results of the Company nor are they intended to be predictive or
projections of future results.

Pursuant to the requirements of SEC Regulation G, whenever we refer
to a non-GAAP financial measure, we will also present in this document,
in the presentation itself or on a Form 8-K in connection with the
presentation on the Investor Relations/Financial Information/Non-GAAP
Financial Measures page of our website,
www.celanese.com,
to the extent practicable, the most directly comparable financial
measure calculated and presented in accordance with GAAP, along with a
reconciliation of the differences between the non-GAAP financial measure
we reference and such comparable GAAP financial measure.

This document includes definitions and reconciliations of non-GAAP
financial measures used from time to time by the Company.

Specific Measures Used

This document provides information about the following non-GAAP
measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA,
operating EBITDA margin, operating profit (loss) attributable to
Celanese Corporation, adjusted earnings per share, net debt, free cash
flow and return on invested capital (adjusted). The most directly
comparable financial measure presented in accordance with US GAAP in our
consolidated financial statements for adjusted EBIT and operating EBITDA
is net earnings (loss) attributable to Celanese Corporation; for
adjusted EBIT margin and operating EBITDA margin is operating margin;
for operating profit (loss) attributable to Celanese Corporation is
operating profit (loss); for adjusted earnings per share is earnings
(loss) from continuing operations attributable to Celanese Corporation
per common share-diluted; for net debt is total debt; for free cash flow
is net cash provided by (used in) operations; and for return on invested
capital (adjusted) is net earnings (loss) attributable to Celanese
Corporation divided by the sum of the average of beginning and end of
the year short- and long-term debt and Celanese Corporation
stockholders’ equity.

Definitions

  • Adjusted EBIT is a performance measure used by the Company and is
    defined by the Company as net earnings (loss) attributable to Celanese
    Corporation, plus (earnings) loss from discontinued operations, less
    interest income, plus interest expense, plus refinancing expense and
    taxes, and further adjusted for Certain Items (refer to Table 8). We
    believe that adjusted EBIT provides transparent and useful information
    to management, investors, analysts and other parties in evaluating and
    assessing our primary operating results from period-to-period after
    removing the impact of unusual, non-operational or
    restructuring-related activities that affect comparability. Our
    management recognizes that adjusted EBIT has inherent limitations
    because of the excluded items. Adjusted EBIT is one of the measures
    management uses for planning and budgeting, monitoring and evaluating
    financial and operating results and as a performance metric in the
    Company’s incentive compensation plan. We may provide guidance on
    adjusted EBIT but are unable to reconcile forecasted adjusted EBIT to
    a US GAAP financial measure without unreasonable efforts because a
    forecast of Certain Items, such as mark-to-market pension gains and
    losses, which may be significant, is not practical. Adjusted EBIT
    margin is defined by the Company as adjusted EBIT divided by net
    sales. Adjusted EBIT margin has the same uses and limitations as
    Adjusted EBIT.
  • Adjusted EBIT by core (i.e. Acetyl Chain and/or Materials
    Solutions) may also be referred to by management as core income.
    Adjusted EBIT margin by core may also be referred to by management as
    core income margin. Adjusted EBIT by business segment may also be
    referred to by management as segment income. Adjusted EBIT margin by
    business segment may also be referred to by management as segment
    income margin.
  • Operating EBITDA is a performance measure used by the Company and
    is defined by the Company as net earnings (loss) attributable to
    Celanese Corporation, plus (earnings) loss from discontinued
    operations, less interest income, plus interest expense, plus
    refinancing expense, taxes and depreciation and amortization, and
    further adjusted for Certain Items, which Certain Items include
    accelerated depreciation and amortization expense. Operating EBITDA is
    equal to adjusted EBIT plus depreciation and amortization. We believe
    that Operating EBITDA provides transparent and useful information to
    investors, analysts and other parties in evaluating our operating
    performance relative to our peer companies. Operating EBITDA margin is
    defined by the Company as Operating EBITDA divided by net sales.
    Operating EBITDA margin has the same uses and limitations as Operating
    EBITDA.
  • Operating profit (loss) attributable to Celanese Corporation is
    defined by the Company as operating profit (loss), less earnings
    (loss) attributable to noncontrolling interests (“NCI”). We believe
    that operating profit (loss) attributable to Celanese Corporation
    provides transparent and useful information to management, investors,
    analysts and other parties in evaluating our core operational
    performance. Operating margin attributable to Celanese Corporation is
    defined by the Company as operating profit (loss) attributable to
    Celanese Corporation divided by net sales. Operating margin
    attributable to Celanese Corporation has the same uses and limitations
    as Operating profit (loss) attributable to Celanese Corporation.
  • Adjusted earnings per share is a performance measure used by the
    Company and is defined by the Company as earnings (loss) from
    continuing operations attributable to Celanese Corporation, adjusted
    for income tax (provision) benefit, Certain Items, and refinancing and
    related expenses, divided by the number of basic common shares and
    dilutive restricted stock units and stock options calculated using the
    treasury method. We believe that adjusted earnings per share provides
    transparent and useful information to management, investors, analysts
    and other parties in evaluating and assessing our primary operating
    results from period-to-period after removing the impact of the above
    stated items that affect comparability and as a performance metric in
    the Company’s incentive compensation plan. We may provide guidance on
    adjusted earnings per share but are unable to reconcile forecasted
    adjusted earnings per share to a GAAP financial measure without
    unreasonable efforts because a forecast of Certain Items, such as
    mark-to-market pension gains and losses, which may be significant, is
    not practical.

    Note: The income tax expense
    (benefit) on Certain Items (“Non-GAAP adjustments”) is determined
    using the applicable rates in the taxing jurisdictions in which the
    Non-GAAP adjustments occurred and includes both current and deferred
    income tax expense (benefit). The income tax rate used for adjusted
    earnings per share approximates the midpoint in a range of forecasted
    tax rates for the year. This range may include certain partial or
    full-year forecasted tax opportunities and related costs, where
    applicable, and specifically excludes changes in uncertain tax
    positions, discrete recognition of GAAP items on a quarterly basis,
    other pre-tax items adjusted out of our GAAP earnings for adjusted
    earnings per share purposes and changes in management’s assessments
    regarding the ability to realize deferred tax assets for GAAP. In
    determining the adjusted earnings per share tax rate, we reflect the
    impact of foreign tax credits when utilized, or expected to be
    utilized, absent discrete events impacting the timing of foreign tax
    credit utilization. We analyze this rate quarterly and adjust it if
    there is a material change in the range of forecasted tax rates; an
    updated forecast would not necessarily result in a change to our tax
    rate used for adjusted earnings per share. The adjusted tax rate is an
    estimate and may differ from the actual tax rate used for GAAP
    reporting in any given reporting period. Table 3a summarizes the
    reconciliation of our estimated GAAP effective tax rate to the
    adjusted tax rate. The estimated GAAP rate excludes discrete
    recognition of GAAP items due to our inability to forecast such items.
    As part of the year-end reconciliation, we will update the
    reconciliation of the GAAP effective tax rate to the adjusted tax rate
    for actual results.

  • Free cash flow is a liquidity measure used by the Company and is
    defined by the Company as net cash provided by (used in) operations,
    less capital expenditures on property, plant and equipment, and
    adjusted for capital contributions from or distributions to Mitsui &
    Co., Ltd. (“Mitsui”) related to our methanol joint venture, Fairway
    Methanol LLC (“Fairway”). We believe that free cash flow provides
    useful information to management, investors, analysts and other
    parties in evaluating the Company’s liquidity and credit quality
    assessment because it provides an indication of the long-term cash
    generating ability of our business. Although we use free cash flow as
    a measure to assess the liquidity generated by our business, the use
    of free cash flow has important limitations, including that free cash
    flow does not reflect the cash requirements necessary to service our
    indebtedness, lease obligations, unconditional purchase obligations or
    pension and postretirement funding obligations.
  • Net debt is defined by the Company as total debt less cash and cash
    equivalents. We believe that net debt provides useful information to
    management, investors, analysts and other parties in evaluating
    changes to the Company’s capital structure and credit quality
    assessment.
  • Return on invested capital (adjusted) is defined by the Company as
    adjusted EBIT, tax effected using the adjusted tax rate, divided by
    the sum of the average of beginning and end of the year short- and
    long-term debt and Celanese Corporation stockholders’ equity. We
    believe that return on invested capital (adjusted) provides useful
    information to management, investors, analysts and other parties in
    order to assess our income generation from the point of view of our
    stockholders and creditors who provide us with capital in the form of
    equity and debt and whether capital invested in the Company yields
    competitive returns. In addition, achievement of certain predetermined
    targets relating to return on invested capital (adjusted) is one of
    the factors we consider in determining the amount of performance-based
    compensation received by our management.

Supplemental Information

Supplemental Information we believe to be of interest to investors,
analysts and other parties includes the following:

  • Net sales for Materials Solutions, the Acetyl Chain and each of our
    business segments and the percentage increase or decrease in net sales
    attributable to price, volume, currency and other factors for
    Materials Solutions, the Acetyl Chain and each of our business
    segments.
  • Cash dividends received from our equity and cost investments.
  • For those consolidated ventures in which the Company owns or is
    exposed to less than 100% of the economics, the outside stockholders’
    interests are shown as NCI. Beginning in 2014, this includes Fairway
    for which the Company’s ownership percentage is 50%. Amounts referred
    to as “attributable to Celanese Corporation” are net of any applicable
    NCI.

Results Unaudited

The results in this document, together with the adjustments made to
present the results on a comparable basis, have not been audited and are
based on internal financial data furnished to management. Quarterly
results should not be taken as an indication of the results of
operations to be reported for any subsequent period or for the full
fiscal year.

 
 

Table 1 – Adjusted EBIT and Operating EBITDA – Reconciliation
of Non-GAAP Measures – Unaudited

                               
Q3 ’17 Q2 ’17 Q1 ’17 2016 Q4 ’16 Q3 ’16 Q2 ’16 Q1 ’16
(In $ millions)
Net earnings (loss) attributable to Celanese Corporation 226 231 183 900 160 262 221 257
(Earnings) loss from discontinued operations 4 8 2 3 (1 )
Interest income (1 ) (1 ) (2 ) (1 ) (1 )
Interest expense 32 30 29 120 29 28 30 33
Refinancing expense 6 4 2
Income tax provision (benefit) 57 40 56 122 (5 ) 15 52 60

Certain Items attributable to Celanese Corporation (Table 8)

27   18   65   130   106   7   9   8  
Adjusted EBIT 345 326 333 1,278 289 319 312 358
Depreciation and amortization expense(1) 78   75   71   288   71   71   73   73  
Operating EBITDA 423   401   404   1,566   360   390   385   431  
 
 
Q3 ’17 Q2 ’17 Q1 ’17 2016 Q4 ’16 Q3 ’16 Q2 ’16 Q1 ’16
(In $ millions)
Advanced Engineered Materials
Consumer Specialties 1 1
Industrial Specialties 2
Acetyl Intermediates
Other Activities(2)       1   1        
Accelerated depreciation and amortization expense 2 2 1 1
Depreciation and amortization expense(1) 78   75   71   288   71   71   73   73  
Total depreciation and amortization expense 80   75   71   290   72   72   73   73  

 

______________________________

(1)

 

Excludes accelerated depreciation and amortization expense as
detailed in the table above, which amounts are included in Certain
Items above.

(2)

Other Activities includes corporate Selling, general and
administrative (“SG&A”) expenses, the results of captive insurance
companies and certain components of net periodic benefit cost
(interest cost, expected return on plan assets and net actuarial
gains and losses).

 
 

Table 2 – Supplemental Segment Data and Reconciliation of
Segment Adjusted EBIT and Operating EBITDA – Non-GAAP Measures –
Unaudited

                                                               
Q3 ’17 Q2 ’17 Q1 ’17 2016 Q4 ’16 Q3 ’16 Q2 ’16 Q1 ’16
(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin
Materials Solutions 150 20.5 % 146 20.6 % 166 23.5 % 652 27.5 % 163 27.7 % 161 27.3 % 162 27.0 % 166 27.9 %
Acetyl Chain(1) 148 17.1 % 135 16.3 % 52 6.5 % 446 14.2 % 86 11.5 % 108 14.2 % 107 13.7 % 145 17.3 %
Other Activities(2) (46 ) (41 ) (26 ) (205 ) (132 ) (23 ) (26 ) (24 )
Total 252   16.1 % 240   15.9 % 192   13.1 % 893   16.6 % 117   8.9 % 246   18.6 % 243   18.0 % 287   20.4 %
Less: Net Earnings (Loss) Attributable to NCI(1) 2   2   1   6   1   1   2   2  
Operating Profit (Loss) Attributable to Celanese Corporation 250   16.0 % 238   15.8 % 191   13.0 % 887   16.5 % 116   8.8 % 245   18.5 % 241   17.8 % 285   20.3 %
Operating Profit (Loss) / Operating Margin Attributable to
Celanese Corporation
Advanced Engineered Materials 97 17.9 % 97 18.8 % 98 20.1 % 350 24.2 % 87 23.9 % 93 25.5 % 82 22.5 % 88 25.1 %
Consumer Specialties 53   28.3 % 49   25.4 % 68   31.2 % 302   32.5 % 76   33.8 % 68   30.2 % 80   34.0 % 78   32.0 %
Total Materials Solutions 150   20.5 % 146   20.6 % 166   23.5 % 652   27.5 % 163   27.7 % 161   27.3 % 162   27.0 % 166   27.9 %
Industrial Specialties 20 7.6 % 26 9.9 % 25 10.2 % 105 10.7 % 20 9.1 % 25 10.2 % 29 11.1 % 31 12.3 %
Acetyl Intermediates(1) 126 18.4 % 107 16.5 % 26 4.2 % 334 13.7 % 65 10.9 % 82 13.9 % 75 12.7 % 112 16.9 %
Eliminations       1       1    
Total Acetyl Chain 146   16.9 % 133   16.1 % 51   6.4 % 440   14.0 % 85   11.3 % 107   14.0 % 105   13.5 % 143   17.0 %
Other Activities(2) (46 ) (41 ) (26 ) (205 ) (132 ) (23 ) (26 ) (24 )
Total 250   16.0 % 238   15.8 % 191   13.0 % 887   16.5 % 116   8.8 % 245   18.5 % 241   17.8 % 285   20.3 %
Equity Earnings, Cost-Dividend Income, Other Income (Expense)
Attributable to Celanese Corporation
Advanced Engineered Materials 45 38 42 122 31 33 27 31
Consumer Specialties 26   28   30   110   27   27   28   28  
Total Materials Solutions 71   66   72   232   58   60   55   59  
Industrial Specialties
Acetyl Intermediates 1   2   1   7   2   1   2   2  
Total Acetyl Chain 1   2   1   7   2   1   2   2  
Other Activities(2) (4 ) 2   4   22   7   6   5   4  
Total 68   70   77   261   67   67   62   65  

Certain Items Attributable to Celanese Corporation (Table 8)

Advanced Engineered Materials 5 7 3 7 3 1 2 1
Consumer Specialties   2   2   6   3   3      
Total Materials Solutions 5   9   5   13   6   4   2   1  
Industrial Specialties 3 1 (2 ) 1 2
Acetyl Intermediates 7   (3 ) 56   6   1   1   3   1  
Total Acetyl Chain 10   (3 ) 56   7   (1 ) 1   4   3  
Other Activities(2) 12   12   4   110   101   2   3   4  
Total 27   18   65   130   106   7   9   8  
Adjusted EBIT / Adjusted EBIT Margin
Advanced Engineered Materials 147 27.1 % 142 27.5 % 143 29.4 % 479 33.2 % 121 33.2 % 127 34.8 % 111 30.4 % 120 34.3 %
Consumer Specialties 79   42.2 % 79   40.9 % 100   45.9 % 418   45.0 % 106   47.1 % 98   43.6 % 108   46.0 % 106   43.4 %
Total Materials Solutions 226   31.0 % 221   31.2 % 243   34.5 % 897   37.8 % 227   38.5 % 225   38.1 % 219   36.5 % 226   38.0 %
Industrial Specialties 23 8.7 % 26 9.9 % 25 10.2 % 106 10.8 % 18 8.2 % 25 10.2 % 30 11.5 % 33 13.0 %
Acetyl Intermediates 134 19.6 % 106 16.3 % 83 13.4 % 347 14.2 % 68 11.4 % 84 14.3 % 80 13.5 % 115 17.3 %
Eliminations       1       1    
Total Acetyl Chain 157   18.2 % 132   16.0 % 108   13.6 % 454   14.5 % 86   11.5 % 109   14.3 % 111   14.2 % 148   17.6 %
Other Activities(2) (38 ) (27 ) (18 ) (73 ) (24 ) (15 ) (18 ) (16 )
Total 345   22.0 % 326   21.6 % 333   22.6 % 1,278   23.7 % 289   22.0 % 319   24.1 % 312   23.1 % 358   25.5 %

 

___________________________

(1)

 

Net earnings (loss) attributable to NCI is included within the
Acetyl Intermediates segment.

(2)

Other Activities includes corporate SG&A expenses, the results of
captive insurance companies and certain components of net periodic
benefit cost (interest cost, expected return on plan assets and
net actuarial gains and losses).

 
 

Table 2 – Supplemental Segment Data and Reconciliation of
Segment Adjusted EBIT and Operating EBITDA – Non-GAAP Measures –
Unaudited (cont.)

                                 
Q3 ’17 Q2 ’17 Q1 ’17 2016 Q4 ’16 Q3 ’16 Q2 ’16 Q1 ’16
(In $ millions, except percentages)
Depreciation and Amortization Expense(1)
Advanced Engineered Materials 29 26 24 92 21 22 25 24
Consumer Specialties 11   11   11   44   11   11   11   11  
Total Materials Solutions 40   37   35   136   32   33   36   35  
Industrial Specialties 8 10 8 34 9 9 8 8
Acetyl Intermediates 26   26   26   107   26   27   27   27  
Total Acetyl Chain 34   36   34   141   35   36   35   35  
Other Activities(2) 4   2   2   11   4   2   2   3  
Total 78   75   71   288   71   71   73   73  
Operating EBITDA / Operating EBITDA Margin
Advanced Engineered Materials 176 32.4 % 168 32.6 % 167 34.3 % 571 39.5 % 142 39.0 % 149 40.8 % 136 37.3 % 144 41.1 %
Consumer Specialties 90   48.1 % 90   46.6 % 111   50.9 % 462   49.7 % 117   52.0 % 109   48.4 % 119   50.6 % 117   48.0 %
Total Materials Solutions 266   36.4 % 258   36.4 % 278   39.4 % 1,033   43.5 % 259   44.0 % 258   43.7 % 255   42.5 % 261   43.9 %
Industrial Specialties 31 11.7 % 36 13.7 % 33 13.5 % 140 14.3 % 27 12.3 % 34 13.9 % 38 14.5 % 41 16.2 %
Acetyl Intermediates 160 23.4 % 132 20.3 % 109 17.6 % 454 18.6 % 94 15.7 % 111 18.8 % 107 18.1 % 142 21.4 %
Eliminations       1       1    
Total Acetyl Chain 191   22.1 % 168   20.3 % 142   17.9 % 595   19.0 % 121   16.2 % 145   19.0 % 146   18.7 % 183   21.8 %
Other Activities(2) (34 ) (25 ) (16 ) (62 ) (20 ) (13 ) (16 ) (13 )
Total 423   27.0 % 401   26.6 % 404   27.5 % 1,566   29.1 % 360   27.5 % 390   29.5 % 385   28.5 % 431   30.7 %

 

___________________________

(1)

 

Excludes accelerated depreciation and amortization expense, which
amounts are included in Certain Items above. See Table 1 for
details.

(2)

Other Activities includes corporate SG&A expenses, the results of
captive insurance companies and certain components of net periodic
benefit cost (interest cost, expected return on plan assets and
net actuarial gains and losses).

 
 
Table 3
Adjusted Earnings (Loss) per Share – Reconciliation of a Non-GAAP
Measure – Unaudited
 
    Q3 ’17   Q2 ’17   Q1 ’17   2016   Q4 ’16   Q3 ’16   Q2 ’16   Q1 ’16
  per   per   per   per   per   per   per   per
share share share share share share share share
(In $ millions, except per share data)
Earnings (loss) from continuing operations attributable to Celanese
Corporation
230 1.68 239 1.72 183 1.30 902 6.19 160 1.12 265 1.83 221 1.50 256 1.73
Income tax provision (benefit) 57 40 56 122 (5) 15 52 60
Earnings (loss) from continuing operations before tax 287 279 239 1,024 155 280 273 316

Certain Items attributable to Celanese Corporation (Table 8)

27 18 65 130 106 7 9 8
Refinancing and related expenses 6 4 2
Adjusted earnings (loss) from continuing operations before tax 314 297 304 1,160 261 291 282 326
Income tax (provision) benefit on adjusted earnings(1) (50) (48) (49) (197) (44) (49) (48) (55)
Adjusted earnings (loss) from continuing operations(2) 264 1.93 249 1.79 255 1.81 963 6.61 217 1.52 242 1.67 234 1.59 271 1.83
Diluted shares (in millions)(3)
Weighted average shares outstanding 136.6 138.6 140.6 144.9 141.9 144.0 146.5 147.4
Incremental shares attributable to equity awards 0.4 0.4 0.4 0.8 0.7 0.6 0.6 0.7
Total diluted shares 137.0 139.0 141.0 145.7 142.6 144.6 147.1 148.1
 
 
______________________________

(1) Calculated using adjusted effective tax rates
(Table 3a) as follows:

Q3 ’17 Q2 ’17 Q1 ’17 2016 Q4 ’16 Q3 ’16 Q2 ’16 Q1 ’16
(In percentages)
Adjusted effective tax rate 16 16 16 17 17 17 17 17
 
 

(2) Excludes the immediate recognition of actuarial
gains and losses and the impact of actual vs. expected plan asset
returns.

    Expected
Actual Plan Plan Asset

Asset Returns

Returns
(In percentages)

2016

6.9 7.3
 

(3) Potentially dilutive shares are included in the
adjusted earnings per share calculation when adjusted earnings are
positive.

 
 
Table 3a
Adjusted Tax Rate – Reconciliation of a Non-GAAP Measure –
Unaudited
 
    Estimated     Actual
2017 2016
(In percentages)
US GAAP effective tax rate 18 12
Discrete quarterly recognition of GAAP items(1) (1 ) 1
Tax impact of other charges and adjustments(2) (1 ) 3
Utilization of foreign tax credits
Changes in valuation allowances, excluding impact of other charges
and adjustments(3)
2
Other(4)   (1 )
Adjusted tax rate 16   17  
______________________________

Note: As part of the year-end reconciliation, we will update
the reconciliation of the GAAP effective tax rate for actual
results.

(1)

 

Such as changes in tax laws, deferred taxes on outside basis
differences, changes in uncertain tax positions and prior year
audit adjustments.

(2)

Reflects the tax impact on pre-tax adjustments presented in
Certain Items (Table 8), which are excluded from pre-tax income
for adjusted earnings per share purposes.

(3)

Reflects changes in valuation allowances related to changes in
judgment regarding the realizability of deferred tax assets or
current year operations, excluding other charges and adjustments.

(4)

Tax impacts related to full-year forecasted tax opportunities and
related costs.

 
 
Table 4
Net Sales by Segment – Unaudited
 
    Q3 ’17   Q2 ’17   Q1 ’17   2016   Q4 ’16   Q3 ’16   Q2 ’16   Q1 ’16
(In $ millions)
Advanced Engineered Materials 543 516 487 1,444 364 365 365 350
Consumer Specialties 187   193   218   929   225   225   235   244  
Total Materials Solutions 730   709   705   2,373   589   590   600   594  
Industrial Specialties 264 262 245 979 219 245 262 253
Acetyl Intermediates 684 649 619 2,441 597 589 592 663
Eliminations(1) (85 ) (85 ) (70 ) (288 ) (67 ) (71 ) (74 ) (76 )
Total Acetyl Chain 863   826   794   3,132   749   763   780   840  
Other Activities(2)
Intersegment eliminations(1) (27 ) (25 ) (28 ) (116 ) (27 ) (30 ) (29 ) (30 )
Net sales 1,566   1,510   1,471   5,389   1,311   1,323   1,351   1,404  
 
___________________________

(1) Includes intersegment sales as follows:

Q3 ’17 Q2 ’17 Q1 ’17 2016 Q4 ’16 Q3 ’16 Q2 ’16 Q1 ’16
(In $ millions)
Industrial Specialties (1 ) (1 ) (1 ) (3 ) (1 ) (1 ) (1 )
Acetyl Intermediates (111 ) (109 ) (97 ) (401 ) (93 ) (100 ) (102 ) (106 )
Intersegment eliminations (112 ) (110 ) (98 ) (404 ) (94 ) (101 ) (103 ) (106 )
 

(2) Other Activities includes corporate SG&A expenses,
the results of captive insurance companies and certain components
of net periodic benefit cost (interest cost, expected return on
plan assets and net actuarial gains and losses).

 
 
Table 4a
Factors Affecting Segment Net Sales Sequentially – Unaudited
 
Three Months Ended September 30, 2017 Compared to Three Months
Ended June 30, 2017
 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 2 3 5
Consumer Specialties (4 ) 1 (3 )
Total Materials Solutions (1 ) 1 3 3
 
Industrial Specialties (4 ) 2 3 1
Acetyl Intermediates 3 (1 ) 3 5
Total Acetyl Chain 1 3 4
 
Total Company 1 3 4
 
 

Three Months Ended June 30, 2017 Compared to Three Months Ended
March 31, 2017

 
    Volume     Price     Currency     Other     Total  
(In percentages)
Advanced Engineered Materials 4 2 6

(1)

Consumer Specialties (10 ) (2 ) (12 )
Total Materials Solutions (1 ) 1
 
Industrial Specialties 2 3 2 7
Acetyl Intermediates (1 ) 5 1 5
Total Acetyl Chain 5 1 (2 ) 4
 
Total Company 3 1 (1 ) 3
 
 

Three Months Ended March 31, 2017 Compared to Three Months
Ended December 31, 2016

 
    Volume     Price     Currency     Other     Total  
(In percentages)
Advanced Engineered Materials 35 (1 ) 34

(2)

Consumer Specialties 3 (6 ) (3 )
Total Materials Solutions 22 (2 ) 20
 
Industrial Specialties 11 1 12
Acetyl Intermediates (2 ) 6 4
Total Acetyl Chain 2 5 (1 ) 6
 
Total Company 11 2 (1 ) 12
___________________________

(1)

 

2017 includes the effect of the acquisition of the nylon
compounding division of Nilit Group.

(2)

2017 includes the effect of the SO.F.TER. S.p.A. acquisition.

 
 

Three Months Ended December 31, 2016 Compared to Three Months
Ended September 30, 2016

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 1 (1 )
Consumer Specialties 2 (2 )
Total Materials Solutions 2 (1 ) (1 )
 
Industrial Specialties (7 ) (2 ) (2 ) (11 )
Acetyl Intermediates 2 (1 ) 1
Total Acetyl Chain (2 ) 1 (2 ) 1 (2 )
 
Total Company (1 ) 1 (1 ) (1 )
 
 

Three Months Ended September 30, 2016 Compared to Three Months
Ended June 30, 2016

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials (1 ) 1
Consumer Specialties (4 ) (4 )
Total Materials Solutions (2 ) (2 )
 
Industrial Specialties (6 ) (1 ) (7 )
Acetyl Intermediates
Total Acetyl Chain (2 ) (1 ) 1 (2 )
 
Total Company (2 ) (2 )
 
 

Three Months Ended June 30, 2016 Compared to Three Months Ended
March 31, 2016

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 6 (2 ) 1 5
Consumer Specialties (3 ) (1 ) (4 )
Total Materials Solutions 2 (2 ) 1 1
 
Industrial Specialties 4 (1 ) 1 4
Acetyl Intermediates (11 ) (11 )
Total Acetyl Chain (7 ) (1 ) 1 (7 )
 
Total Company (4 ) (1 ) 1 (4 )
 
 
Table 4a
Factors Affecting Segment Net Sales Sequentially – Unaudited
(cont.)
 
Three Months Ended March 31, 2016 Compared to Three Months Ended
December 31, 2015
 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 12 12
Consumer Specialties 6 (7 ) (1 )
Total Materials Solutions 10 (3 ) 7
 
Industrial Specialties 9 (3 ) 6
Acetyl Intermediates 7 (4 ) 3
Total Acetyl Chain 8 (4 ) (1 ) 3
 
Total Company 9 (4 ) 5
 
 
Table 4b
Factors Affecting Segment Net Sales Year Over Year – Unaudited
 
Three Months Ended September 30, 2017 Compared to Three Months
Ended September 30, 2016
 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 49 (2 ) 2 49
Consumer Specialties (10 ) (8 ) 1 (17 )
Total Materials Solutions 26 (4 ) 2 24
 
Industrial Specialties 2 4 2 8
Acetyl Intermediates (1 ) 16 1 16
Total Acetyl Chain 13 2 (2 ) 13
 
Total Company 11 6 2 (1 ) 18
 
 

Three Months Ended June 30, 2017 Compared to Three Months Ended
June 30, 2016

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 44 (2 ) (1 ) 41
Consumer Specialties (9 ) (9 ) (18 )
Total Materials Solutions 23 (4 ) (1 ) 18
 
Industrial Specialties (1 ) 3 (2 )
Acetyl Intermediates (4 ) 14 (1 ) 1 10
Total Acetyl Chain (3 ) 12 (2 ) (1 ) 6
 
Total Company 8 5 (1 ) 12
 
 

Three Months Ended March 31, 2017 Compared to Three Months
Ended March 31, 2016

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 44 (3 ) (2 ) 39
Consumer Specialties (2 ) (8 ) (1 ) (11 )
Total Materials Solutions 25 (5 ) (1 ) 19
 
Industrial Specialties 1 (2 ) (2 ) (3 )
Acetyl Intermediates (12 ) 7 (2 ) (7 )
Total Acetyl Chain (9 ) 5 (2 ) 1 (5 )
 
Total Company 5 1 (2 ) 1 5
 
 

Three Months Ended December 31, 2016 Compared to Three Months
Ended December 31, 2015

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 20 (2) (1) 17
Consumer Specialties 2 (11) (9)
Total Materials Solutions 12 (6) 6
 
Industrial Specialties (1) (6) (1) (8)
Acetyl Intermediates (4) (2) (2) 1 (7)
Total Acetyl Chain (4) (3) (2) 1 (8)
 
Total Company 2 (4) (1) 1 (2)
 
 

Three Months Ended September 30, 2016 Compared to Three Months
Ended September 30, 2015

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 16 (4 ) 12
Consumer Specialties (2 ) (7 ) (9 )
Total Materials Solutions 8 (5 ) 3
 
Industrial Specialties (1 ) (9 ) (1 ) (11 )
Acetyl Intermediates (3 ) (11 ) 1 (13 )
Total Acetyl Chain (3 ) (12 ) 2 (13 )
 
Total Company 1 (9 ) 2 (6 )
 
 

Three Months Ended June 30, 2016 Compared to Three Months Ended
June 30, 2015

 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 8 (4 ) 1 5
Consumer Specialties 2 (8 ) (6 )
Total Materials Solutions 5 (5 ) 1 1
 
Industrial Specialties (1 ) (8 ) (9 )
Acetyl Intermediates (5 ) (13 ) 2 (16 )
Total Acetyl Chain (4 ) (12 ) 2 (14 )
 
Total Company (10 ) 1 (9 )
 
 
Table 4b
Factors Affecting Segment Net Sales Year Over Year – Unaudited
(cont.)
 
Three Months Ended March 31, 2016 Compared to Three Months Ended
March 31, 2015
 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 5 (2) (1) 2
Consumer Specialties 17 (9) 8
Total Materials Solutions 9 (5) 4
 
Industrial Specialties (9) (1) (10)
Acetyl Intermediates 6 (13) (2) 2 (7)
Total Acetyl Chain 5 (13) (2) 1 (9)
 
Total Company 7 (10) (2) 1 (4)
 
 
Table 4c
Factors Affecting Segment Net Sales Year Over Year – Unaudited
 
Year Ended December 31, 2016 Compared to Year Ended December 31,
2015
 
    Volume     Price     Currency     Other     Total
(In percentages)
Advanced Engineered Materials 11 (2 ) 9
Consumer Specialties 4 (8 ) (4 )
Total Materials Solutions 8 (5 ) 3
 
Industrial Specialties (1 ) (8 ) (1 ) (10 )
Acetyl Intermediates (2 ) (10 ) (1 ) 2 (11 )
Total Acetyl Chain (2 ) (10 ) (1 ) 2 (11 )
 
Total Company 2 (8 ) (1 ) 2 (5 )
 
 
Table 5
Free Cash Flow – Reconciliation of a Non-GAAP Measure – Unaudited
 
    Q3 ’17     Q2 ’17     Q1 ’17     2016     Q4 ’16     Q3 ’16     Q2 ’16     Q1 ’16
(In $ millions)
Net cash provided by (used in) investing activities (68 ) (325 ) (64 ) (439 ) (247 ) (54 ) (63 ) (75 )
Net cash provided by (used in) financing activities (247 ) 21 (270 ) (759 ) (292 ) 265 (259 ) (473 )
 
Net cash provided by (used in) operating activities 255 298 192 893 (47 ) 304 349 287
Capital expenditures on property, plant and equipment (64 ) (54 ) (62 ) (246 ) (60 ) (58 ) (58 ) (70 )
Capital (distributions to) contributions from NCI (10 ) (4 ) (4 ) (24 ) (9 ) (9 ) (6 )  
Free cash flow(1)(2) 181   240   126   623   (116 ) 237   285   217  
______________________________

(1)

 

Free cash flow is a liquidity measure used by the Company and is
defined by the Company as net cash provided by (used in) operating
activities, less capital expenditures on property, plant and
equipment, and adjusted for capital contributions from or
distributions to Mitsui & Co., Ltd. (“Mitsui”) related to our
joint venture, Fairway Methanol LLC (“Fairway”).

(2)

Excludes required debt service and capital lease payments of $27
million and $56 million for the years ending December 31, 2017 and
2016, respectively.

 
 
Table 6
Cash Dividends Received – Unaudited
 
    Q3 ’17     Q2 ’17     Q1 ’17     2016     Q4 ’16     Q3 ’16     Q2 ’16     Q1 ’16
(In $ millions)
Dividends from equity method investments 5 59 50 131 15 6 73 37
Dividends from cost method investments 24 29 29 108 26 26 29 27
Total 29 88 79 239 41 32 102 64
 
 
Table 7
Net Debt – Reconciliation of a Non-GAAP Measure – Unaudited
 
    Q3 ’17     Q2 ’17     Q1 ’17     2016     Q4 ’16     Q3 ’16     Q2 ’16     Q1 ’16
(In $ millions)
Short-term borrowings and current installments of long-term debt –
third party and affiliates
435 384 107 118 118 92 119 116
Long-term debt, net of unamortized deferred financing costs 2,954   2,931   2,851   2,890   2,890   2,923   2,464   2,487  
Total debt 3,389 3,315 2,958 3,008 3,008 3,015 2,583 2,603
Cash and cash equivalents (461 ) (511 ) (501 ) (638 ) (638 ) (1,252 ) (735 ) (716 )
Net debt 2,928   2,804   2,457   2,370   2,370   1,763   1,848   1,887  
 
 
Table 8
Certain Items – Unaudited
 

The following Certain Items attributable to Celanese Corporation
are included in Net earnings (loss) and are adjustments to
non-GAAP measures:

 
    Q3 ’17     Q2 ’17     Q1 ’17     2016     Q4 ’16     Q3 ’16     Q2 ’16     Q1 ’16     Income Statement Classification
(In $ millions)
Employee termination benefits(1) 2 2 11 3 3 5 Other charges (gains), net
Plant/office closures 2 (3 ) 57 4 1 2 1 Cost of sales / SG&A / R&D / Other charges (gains), net
Business optimization 4 7 3 1 1 2 Cost of sales / SG&A
Asset impairments 2 1 1 Other charges (gains), net
(Gain) loss on disposition of business and assets, net 2 (4 ) (2 ) (2 ) (Gain) loss on disposition, net
Commercial disputes (2 ) (2 ) Other charges (gains), net
Write-off of other productive assets 4 1 1 2 Cost of sales / R&D
Employee benefit plan changes 1 1 1 Cost of sales / SG&A / R&D
Actuarial (gain) loss on pension and postretirement plans 102 102 Cost of sales / SG&A / R&D
Start-up costs 2 1 1 Cost of sales
Mergers and acquisitions 10 7 9 3 2 1 Cost of sales / SG&A
InfraServ ownership change 8 Other charges (gains), net / Equity in net earnings (loss) of
affiliates
Impact from natural disasters(2) 11

 

Cost of sales
Other 1   (3 )       Equity in net earnings (loss) of affiliates
Certain Items attributable to Celanese Corporation 27 18   65   130   106   7   9 8
______________________________

(1)

 

Primarily associated with site shutdown costs.

(2)

Primarily associated with Hurricane Harvey.

 
 
Table 9
Return on Invested Capital (Adjusted) – Presentation of a
Non-GAAP Measure – Unaudited
 
            2016
(In $ millions,
except percentages)
Net earnings (loss) attributable to Celanese Corporation 900
 

Adjusted EBIT (Table 1)

 

1,278
Adjusted effective tax rate (Table 3a) 17 %
Adjusted EBIT tax effected 1,061
 
2016 2015 Average
(In $ millions, except percentages)
Short-term borrowings and current installments of long-term debt –
third parties and affiliates
118 513 316
Long-term debt, net of unamortized deferred financing costs 2,890 2,468 2,679
Celanese Corporation stockholders’ equity 2,588 2,378 2,483  
Invested capital 5,478  
 
Return on invested capital (adjusted) 19.4 %
 
Net earnings (loss) attributable to Celanese Corporation as a
percentage of invested capital
16.4 %

Celanese Corporation
Investor Relations
Surabhi
Varshney, +1-972-443-3078
Surabhi.Varshney@celanese.com
or
Media
– U.S.

Travis Jacobsen, +1-972-443-3750
William.Jacobsen@celanese.com
or
Media
– Europe

Jens Kurth, +49(0)69 45009 1574
Jens.Kurth@celanese.com

Source: Celanese Corporation